Pearson M A, O'Farrell A M, Dexter T M, Whetton A D, Owen-Lynch P J, Heyworth C M
Cancer Research Campaign Laboratories, Paterson Institute for Cancer Research, Manchester, UK.
Growth Factors. 1998;15(4):293-306. doi: 10.3109/08977199809017484.
Stem Cell Factor (SCF), the ligand for the c-kit proto-oncogene, has been shown to synergistically interact with other cytokines, enhancing the responsiveness of haemopoietic precursors. In this study we have examined the effects of SCF, in combination with interleukin-3 (IL-3), on FDCP-Mix A4 cells, a murine, multipotent, haemopoietic progenitor cell line. Low concentration of IL-3 act to enhance cell survival but do not stimulate proliferation in A4 cells. Similarly, SCF when added alone, acts as a good survival stimulus, but is a poor proliferative stimulus. However, in combination with low concentrations of IL-3, SCF stimulates a synergistic enhancement of proliferation leading to a large increase in cell number after seven days. The synergy observed was not due to SCF stimulated alterations in the mRNA, protein levels or affinity of the IL-3 receptors. Therefore, interactions between cytokines at the level of cytoplasmic signalling pathways were investigated. IL-3 stimulated the rapid and transient tyrosine phosphorylation of several proteins (including those of molecular weights 130, 110, 100, 95, 80, 65, 50 and 45 kDa). Some of these proteins were identified as the Src Homology Collagen (SHC) protein, Janus kinase (JAK-2) and the Mitogen Activated Protein Kinase isoforms ERK 1 and ERK 2. IL-3 also stimulated a transient increase in the activity of both ERK 1 and 2. SCF stimulated a rapid and transient increase in the tyrosine phosphorylation of ERK 1 and ERK 2 although, coaddition of SCF with IL-3, caused no gross differences in the phosphorylation of SHC, JAK-2 or ERKs compared to those observed with IL-3 alone. Coaddition of SCF and low concentration of IL-3 stimulated a reproducible synergistic increase in the activity of ERK 2, whereas only an additive increase in the activity of ERK 1 was observed. These results suggest that ERK 2 activation represents a point at which the two pathways, stimulated by IL-3 and SCF, interact synergistically.
干细胞因子(SCF)是原癌基因c-kit的配体,已被证明可与其他细胞因子协同相互作用,增强造血前体细胞的反应性。在本研究中,我们检测了SCF与白细胞介素-3(IL-3)联合作用于FDCP-Mix A4细胞(一种小鼠多能造血祖细胞系)的效果。低浓度的IL-3可增强细胞存活,但不会刺激A4细胞增殖。同样,单独添加SCF时,它是一种良好的存活刺激因子,但却是一种较差的增殖刺激因子。然而,与低浓度的IL-3联合使用时,SCF可刺激增殖协同增强,导致7天后细胞数量大幅增加。观察到的协同作用并非由于SCF刺激了IL-3受体的mRNA、蛋白质水平或亲和力的改变。因此,研究了细胞因子在细胞质信号通路水平上的相互作用。IL-3刺激了几种蛋白质(包括分子量为130、110、100、95、80、65、50和45 kDa的蛋白质)的快速和短暂酪氨酸磷酸化。其中一些蛋白质被鉴定为Src同源胶原(SHC)蛋白、Janus激酶(JAK-2)以及丝裂原活化蛋白激酶亚型ERK 1和ERK 2。IL-3还刺激了ERK 1和ERK 2活性的短暂增加。SCF刺激了ERK 1和ERK 2酪氨酸磷酸化的快速和短暂增加,尽管与单独使用IL-3相比,SCF与IL-3共同添加时,SHC、JAK-2或ERK的磷酸化没有明显差异。SCF和低浓度IL-3共同添加刺激了ERK 2活性的可重复协同增加,而仅观察到ERK 1活性的加性增加。这些结果表明,ERK 2的激活代表了由IL-3和SCF刺激的两条信号通路协同相互作用的一个点。